STOCK TITAN

American Strategic Investment Co. (NYC) Financials

NYC
FY2025 annual
Revenue Not reported for FY2025
Net Income -$21.2M +84.9% YoY
EPS (Diluted) -$8.32 +85.3% YoY
Operating Cash Flow -$7.8M -93.9% YoY
Market Cap $18.2M as of Oct 16, 2026
Price / Sales n/m no revenue reported
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 0.3x on $52.9M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NYC SEC filings page.

This page shows American Strategic Investment Co. (NYC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NYC FY2025

The company’s shrinking balance sheet is paired with rising leverage as a thinner equity base absorbs continued losses.

FY2025’s operating improvement—operating income of $4.4M—did not become cash: operating cash flow was -$7.8M. With $15.3M of interest expense, the company still posted a net loss of $21.2M, showing that financing costs and non-cash or working-capital effects outweighed the reported operating gain.

Total assets fell from $694M in FY2023 to $445M in FY2025, shrinking the balance sheet. Meanwhile, debt-to-equity reached 5.9x from 2.1x, meaning the remaining asset base is supported by a much thinner equity layer.

The accounting recovery was substantial: net loss narrowed from $141M in FY2024 to $21.2M in FY2025. The reported liquidity measure equaled 2 months of the latest annual operating outflow, while operating cash flow remained -$7.8M.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

American Strategic Investment Co. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
2/5

American Strategic Investment Co. passes 2 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality No Cash Backing
N/A

American Strategic Investment Co. reported a net loss of $21.2M while operations used $7.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
0.29x

American Strategic Investment Co. earns $0.29 in operating income for every $1 of interest expense ($4.4M vs $15.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA
$554K
YoY+101.8%
QoQ-46.9%

American Strategic Investment Co.'s EBITDA was $554K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 101.8% from the same quarter a year earlier. Against the prior quarter it is down 46.9%.

Net Income
-$8.3M
YoY+80.1%
QoQ-6.7%

American Strategic Investment Co. reported -$8.3M in net income in Q2 2026. This represents an increase of 80.1% from the same quarter a year earlier. Against the prior quarter it is down 6.7%.

EPS (Diluted)
-$3.04
YoY+81.5%
QoQ0.0%

American Strategic Investment Co. earned -$3.04 per diluted share (EPS) in Q2 2026. This represents an increase of 81.5% from the same quarter a year earlier. It is unchanged from the prior quarter.

Revenue

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$2.4M
YoY-54.4%
QoQ-3.1%
5Y CAGR-36.7%
10Y CAGR-28.9%

American Strategic Investment Co. held $2.4M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding
3M
YoY+20.3%
QoQ+8.3%
5Y CAGR-24.7%
10Y CAGR-20.3%

American Strategic Investment Co. had 3M shares outstanding in Q2 2026. This represents an increase of 20.3% from the same quarter a year earlier. Against the prior quarter it is up 8.3%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Return on Equity
-15.7%
YoY+101.6pp
QoQ-2.1pp

American Strategic Investment Co.'s ROE was -15.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 101.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.1 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Net Margin

Not reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

NYC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NYC quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
SG&A Expenses$2.9M+32.8%$2.3M-26.2%N/A$1.8M-0.4%$2.2M+10.6%$3.1M+11.9%N/A$1.8M-8.8%
Operating Income-$1.9M+94.3%-$1.5M+67.3%N/A$43.0M+247.3%-$33.8M+61.0%-$4.5M-54.6%N/A-$29.2M-527.0%
EBITDA$554K+101.8%$1.0M+213.0%N/A$46.1M+286.0%-$30.3M+62.9%-$924K-139.5%N/A-$24.8M-1447.7%
Interest Expense$4.1M-47.9%$4.0M-0.9%N/A$4.1M-21.9%$7.8M+50.9%$4.1M-13.1%N/A$5.3M+11.4%
Income Tax$0$0N/AN/A$0$0N/AN/A
Net Income-$8.3M+80.1%-$7.8M+9.5%N/A$35.8M+203.7%-$41.7M+54.6%-$8.6M-12.9%N/A-$34.5M-267.2%
EPS (Basic)-$3.04+81.5%-$3.04+10.3%-$2.62-21.3%$13.60+200.6%-$16.39+55.1%-$3.39-3.4%-$2.16+93.5%-$13.52-229.8%
EPS (Diluted)-$3.04+81.5%-$3.04+10.3%-$2.62-21.3%$13.60+200.6%-$16.39+55.1%-$3.39-3.4%-$2.16+93.5%-$13.52-229.8%
Diluted Shares (Avg)3M+7.6%3M+0.9%N/A3M+3.1%3M+0.9%3M+9.1%N/A3M+11.5%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses.

NYC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NYC quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$444.8M-4.1%$445.0M-10.9%$445.2M-12.2%$448.1M-21.1%$464.0M-22.5%$499.4M-27.6%$507.1M-27.0%$567.9M-26.3%
Cash & Equivalents$2.4M-54.4%$2.5M-64.7%$1.3M-86.7%$3.4M-35.9%$5.3M+1.7%$7.1M+33.8%$9.8M+84.7%$5.2M+2.8%
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$391.8M-8.5%$387.9M-8.1%$380.4M-9.7%$376.7M-20.8%$428.5M-9.2%$422.3M-10.6%$421.5M-10.2%$475.5M+0.9%
Current LiabilitiesN/AN/AN/AN/A$99.0MN/AN/AN/A
Non-Current LiabilitiesN/AN/AN/AN/A$329.5MN/AN/AN/A
Total Equity$52.9M+48.9%$57.1M-26.0%$64.8M-24.3%$71.4M-22.7%$35.5M-72.0%$77.1M-64.5%$85.6M-61.9%$92.4M-69.1%
Retained Earnings-$683.1M+1.9%-$674.8M-3.1%-$667.1M-3.3%-$660.4M-3.3%-$696.1M-15.1%-$654.5M-27.6%-$645.9M-27.8%-$639.2M-48.2%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

NYC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NYC quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$352K+114.1%-$182K+94.0%-$3.0M+59.0%$777K-69.7%-$2.5M-173.1%-$3.0M-283.5%-$7.3M-110.3%$2.6M+946.9%
Depreciation & Amortization$2.5M-29.8%$2.5M-29.8%$2.6M-27.6%$3.1M-30.1%$3.5M-31.2%$3.6M-31.7%$3.6M-43.4%$4.4M-32.1%
Stock-Based Compensation$63K-31.5%$91K-1.1%N/A$90K+18.4%$92K-50.5%$92K+70.4%N/A$76K-93.7%
Investing Cash Flow-$397K+18.3%-$101K-40.3%-$34K-100.1%-$3.2M-794.4%-$486K-138.2%-$72K+80.2%$60.8M+1753.1%-$357K+12.5%
Financing Cash Flow-$180K$400K$650K+101.3%$0-100.0%$0-100.0%$0-$50.3M$425K

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

NYC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NYC quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Return on Equity-15.7%+101.6pp-13.6%-2.5ppN/A50.1%+87.4pp-117.3%-44.8pp-11.2%-7.6ppN/A-37.3%-34.2pp
Return on Assets-1.9%+7.1pp-1.8%0.0ppN/A8.0%+14.0pp-9.0%+6.4pp-1.7%-0.6ppN/A-6.1%-4.8pp
Debt-to-Equity7.41-4.7x6.80+1.3x5.87+0.9x5.28+0.1x12.06+8.3x5.48+3.3x4.92+2.8x5.15+3.6x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
American Strategic Investment Co. NYC FY2025 N/A -$21.2M N/A $18.2M —
Ohmyhome Limited OMH FY2025 $9.5M -$7.2M -75.2% $5.3M 2/100
Fangdd Network Group Ltd. DUO FY2025 $50.7M -$12.1M -23.9% $24.9M 5/100
Rafael Holdings, Inc. RFL FY2025 $917K -$30.5M N/A $76.4M —
Gyrodyne, LLC GYRO FY2015 N/A N/A N/A $10.3M —

Frequently Asked Questions

Is American Strategic Investment Co. profitable?

No, American Strategic Investment Co. (NYC) reported a net income of -$21.2M in fiscal year 2025.

What is American Strategic Investment Co.'s earnings per share (EPS)?

American Strategic Investment Co. (NYC) reported diluted earnings per share of -$8.32 for fiscal year 2025. This represents a 85.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is American Strategic Investment Co.'s EBITDA?

American Strategic Investment Co. (NYC) had EBITDA of $17.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

American Strategic Investment Co. (NYC) has a return on equity of -32.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

American Strategic Investment Co. (NYC) recorded an outflow of $7.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

American Strategic Investment Co. (NYC) had $445.2M in total assets as of fiscal year 2025, including both current and long-term assets.

American Strategic Investment Co. (NYC) had 3M shares outstanding as of fiscal year 2025.

American Strategic Investment Co. (NYC) had a debt-to-equity ratio of 5.87 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

American Strategic Investment Co. (NYC) had a return on assets of -4.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

American Strategic Investment Co. (NYC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $18.2M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

American Strategic Investment Co. (NYC) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $18.2M as of Oct 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, American Strategic Investment Co. (NYC) held $1.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $7.8M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

American Strategic Investment Co. (NYC) has a Piotroski F-Score of 2 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

American Strategic Investment Co. (NYC) reported a net loss of $21.2M while operations used $7.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

American Strategic Investment Co. (NYC) has an interest coverage ratio of 0.29x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top